Fair Value Calculator Fair Value Calculator
EN DE

ELLEN (ELLEN) Fair Value & Analysis

Basic Materials · Market cap ₹37.0B

E ELLEN ELLEN · NSE
Price₹262.30
Fair Value₹99.26
Upside-62.2%
Quality38/100
Watch ELLEN for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹61.76 – ₹138.91

Fair value as of: Jul 3, 2026

From 25 valuation models · updated today

Share price +5.8% over the past month.

Price vs Fair Value (12 months)

₹613.30 ₹180.50 Fair Value ₹99.26 Jul 2025 Jul 2026

12‑month range ₹180.50 – ₹613.30 · fair‑value band ₹61.76 – ₹138.91 · the ₹262.30 price screens above the ₹99.26 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ELLEN (ELLEN) currently trades at ₹262.30, while our model-based Fair Value estimate is ₹99.26 — implying the stock looks roughly 62.2% overvalued today. We read business quality at 38/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, ELLEN generated revenue of ₹3.4B at a net margin of 30.6%. Revenue grew 6.0% year over year. It earns a return on equity of 14.2%. Net debt stands at ₹1.8B. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹3.4B
Revenue growth (YoY) +6.0%
Net margin 30.6%
Return on equity 14.2%
Free cash flow ₹26.7M FY2026
P/E ratio 34.8
More key figures
Operating margin 24.1%
EPS (TTM) ₹7.54
EPS growth (YoY) +16.5%
Net debt ₹1.8B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

ELLEN reported revenue of ₹3.4B in FY2026 versus ₹2.5B in FY2022, a compound +8.5%/yr. Reported net income was ₹1.0B in FY2026, compounding +24.0%/yr from FY2022.

Revenue +8.5%/yr
FY22 ₹2.5B
FY23 ₹2.1B
FY24 ₹2.7B
FY25 ₹3.1B
FY26 ₹3.4B
Net income +24.0%/yr
FY22 ₹442M
FY23 ₹281M
FY24 ₹453M
FY25 ₹833M
FY26 ₹1.0B

Is ELLEN fairly valued? → Check now

Similar stocks

6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN €443.00 €109.98 -75%
Shin-Etsu Chemical Co SHECY $22.62 $12.94 -43%
BASF SE BAS €49.17 €23.76 -52%
Ningxia Baofeng Energy Group 600989 ¥23.43 ¥34.39 +47%
Dow Inc D1OW34 R$43.92 R$86.14 +96%
Ganfeng Lithium Group 002460 ¥67.60 ¥22.08 -67%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ELLEN (ELLEN) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹99.26 versus a price of ₹262.30 — about −62% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ELLEN?
Our model-based fair value for ELLEN is ₹99.26 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹262.30.
What is the quality score of ELLEN?
ELLEN has a Quality Score of 38/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ELLEN (ELLEN)?
ELLEN reported trailing-twelve-month revenue of about ₹3.4B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of ELLEN?
The net profit margin of ELLEN is about 30.6%, meaning it keeps roughly 30.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.